National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: neuroendocrine tumors. Version 2.2014. NCCN. http://www.nccn.org. Accessed 14 Apr 2014.
Öberg K, Knigge U, Kwekkeboom D, Perren A; ESMO Guidelines Working Group. Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012 Oct;23(Suppl Suppl 7):vii124-130. http://annonc.oxfordjournals.org/content/23/suppl_7/vii124.full.pdf. Accessed 14 April 2014. PMID: 22997445
Anthony LB, Strosberg JR, Klimstra DS, et al. The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (NETs): well-differentiated NETs of the distal colon and rectum. Pancreas. 2010;39(6):767-774. doi: 10.1097/MPA.0b013e3181ec1261. PMID: 20664474
Boudreaux JP, Klimstra DS, Hassan MM, et al. NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum. Pancreas. 2010;39(6):753-766. doi: 10.1097/MPA.0b013e3181ebb2a5. PMID: 20664473
Kalemkerian GP, Akerley W, Blum MG, et al; National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: small cell lung cancer. NCCN. 2010.
Klimstra DS, Modlin IR, Coppola D, et al. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas. 2010;39(6):707-712. doi: 10.1097/MPA.0b013e3181ec124e. PMID: 20664470
Kocha W, Maroun J, Kennecke H, et al. Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group. Curr Oncol. 2010;17(3):49-64. PMID: 20567626
Kulke MH, Anthony LB, Bushnell DL, et al. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas. 2010;39(6):735-752. doi: 10.1097/MPA.0b013e3181ebb168. PMID: 20664472
Kulke MH, Bergland E, Clark OH, et al; National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: neuroendocrine tumors. NCCN. Mar 2012.
Massironi S, Sciola V, Peracchi M, et al. Neuroendocrine tumors of the gastro-entero-pancreatic system. World J Gastroenterol. 2008 Sep;14(35):5377-5384. PMID: 18803349
Phan AT, Oberg K, Choi J, et al. NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus). Pancreas. 2010;39(6):784-798. doi: 10.1097/MPA.0b013e3181ec1380. PMID: 20664476
Strosberg JR, Coppola D, Klimstra DS, et al. The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas. Pancreas. 2010;39(6):799-800. doi: 10.1097/MPA.0b013e3181ebb56f. PMID: 20664477
Vinik AI, Woltering EA, Warner RR, et al. NANETS consensus guidelines for the diagnosis of neuroendocrine tumor. Pancreas. 2010;39(6):713-734. doi: 10.1097/MPA.0b013e3181ebaffd. PMID: 20664471
Garcia-Carbonero R, JImenez-Fonseca P, Teulé A, Barriuso J, Sevilla I. SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) 2014. Clin Transl Oncol. 2014 Dec;16(12):1025-1034. http://www.ncbi.nlm.nih.gov. Accessed 05 Jan 2016. PMID: 25183048
Kulke MH, Shah MH, Benson AB 3rd, et al; National Comprehensive Cancer Network. Neuroendocrine tumors, version 1.2015. J Natl Compr Canc Netw. 2015 Jan;13(1):78-108. http://www.nccn.org. Accessed 05 Jan 2016. PMID: 25583772
Kunz PL, Reidy-Lagunes D, Anthony LB, et al; North American Neuroendocrine Tumor Society. Consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas. 2013 May;42(4):557-577. https://www.nanets.net. Accessed 05 Jan 2016. PMID: 23591432
American Cancer Society. Gastrointestinal carcinoid tumor stages. American Cancer Society website. https://www.cancer.org. Dec 2017.
American Cancer Society. Pancreatic neuroendocrine tumor stages. American Cancer Society website. https://www.cancer.org. . Dec 2017.
National Comprehensive Cancer Network. Neuroendocrine and adrenal tumors. Version 2.2018. NCCN. https://www.nccn.org/. May 2018.
Singh S, Asa SL, Dey C, et al. Diagnosis and management of gastrointestinal neuroendocrine tumors: an evidence-based Canadian consensus. Cancer Treat Rev. 2016 Jun;47:32-45. doi: 10.1016/j.ctrv.2016.05.003. PMID: 27236421
National Comprehensive Cancer Network (NCCN). Neuroendocrine and adrenal tumors. Version 1.2019. NCCN. https://www.nccn.org/. Mar 2019.
ClinicalKey. Neuroendocrine tumors of the gastrointestinal tract, lung, and thymus (carcinoid tumors). ClinicalKey. https://www.clinicalkey.com. 23 Jan 2023. Accessed 08 Aug 2023.
National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology: neuroendocrine and adrenal tumors version 2.2021. NCCN. http://www.nccn.org. 18 Jun 2021.
Pavel M, Öberg K, Falconi M,et al; ESMO Guidelines Committee. Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020 Jul;31(7):844-860. doi: 10.1016/j.annonc.2020.03.304. Accessed 08. PMID: 32272208
Baudin E, Caplin M, Garcia-Carbonero R, et al; ESMO Guidelines Committee. Lung and thymic carcinoids: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021 Apr;32(4):439-451. doi: 10.1016/j.annonc.2021.01.003. PMID: 33482246
Halfdanarson TR, Strosberg JR, Tang L, et al. The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and medical management of pancreatic neuroendocrine tumors. Pancreas. 2020 Aug;49(7):863-881. doi: 10.1097/MPA.0000000000001597. Accessed 28 Mar 2022. PMID: 32675783
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines): Neuroendocrine and adrenal tumors. Version 4.2021. NCCN. https://www.nccn.org/. Dec 2021.
Strosberg JR. Treatment of the carcinoid syndrome. UpToDate. https://www.uptodate.com/. Feb 2022.
Thomas CF, Jett JR, Strosberg JR. Lung neuroendocrine (carcinoid) tumors: Epidemiology, risk factors, classification, histology, diagnosis, and staging. UpToDate. https://www.uptodate.com/. Jul 2021.
Allendorf J, Chabot J. Surgical resection of sporadic pancreatic neuroendocrine tumors. UpToDate. https://www.uptodate.com. Jun 2023.
Canada Cancer Society. Radiation therapy for neuroendocrine tumors. Canadian Cancer Society. https://cancer.ca/. 2023.
Canada Cancer Society. Symptoms of neuroendocrine tumors. Canadian Cancer Society. https://cancer.ca/. 2023.
Chan J, Kulke M, Clancy T. Metastatic well-differentiated pancreatic neuroendocrine tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion. UpToDate. https://www.uptodate.com. Jun 2023.
Das S, Al-Toubah T, Strosberg J. Chemotherapy in neuroendocrine tumors. Cancers (Basel). 2021 Sep;13(19):4872. doi: 10.3390/cancers13194872. PMID: 34638356
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines): Neuroendocrine and adrenal tumors. Version 2.2021. NCCN. https://www.nccn.org/. Jul 2021.
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines): Neuroendocrine and adrenal tumors. Version 1.2023. NCCN. https://www.nccn.org/. Aug 2022.
Rindi G, Mete O, Uccella S, et al. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol. 2022 Mar;33(1):115-154. doi: 10.1007/s12022-022-09708-2. PMID: 35294740
Shah MH, Goldner WS, Benson AB, et al. Neuroendocrine and adrenal tumors, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021 Jul;19(7):839-868. doi: 10.6004/jnccn.2021.0032. PMID: 34340212
Sorbye, H, Grande E, Pavel M, et al. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma. J Neuroendocrinol. 2023 Mar;35(3):e13249. doi: 10.1111/jne.13249. Accessed 08 Aug 2023
Strosberg J, Del Rivero J. Overview of tumor biomarkers in gastroenteropancreatic neuroendocrine tumors. UpToDate. https://www.uptodate.com. Jun 2023.
Strosberg J, Gangi A. Staging, treatment, and post-treatment surveillance of non-metastatic, well-differentiated gastrointestinal tract neuroendocrine (carcinoid) tumors. UpToDate. https://www.uptodate.com. Jun 2023.
Yang Z. Pathology, classification, and grading of neuroendocrine neoplasms arising in the digestive system. UpToDate. https://www.uptodate.com. Jun 2023.
National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology (NCCN guidelines): Neuroendocrine and adrenal tumors. Version 2.2024. NCCN. https://www.nccn.org/. 01 Aug 2024.
National Institute for Health and Care Excellence (NICE). Selective internal radiation therapy for neuroendocrine tumours that have metastasised to the liver. NICE. https://www.nice.org.uk/. 16 May 2024.
